Literature DB >> 2400966

An evaluation of the prognostic significance of HLA-DR expression in gastric carcinoma.

D A Hilton1, K P West.   

Abstract

The prognostic value of histochemical staining for HLA-DR was assessed retrospectively in 52 "curative" gastrectomy specimens from patients with gastric carcinoma. In addition other tumor variables, including histologic type, degree of differentiation, extent of local spread, prominence of mononuclear infiltrate, tumor edge, and lymph-node metastases, were examined. Sixty-five percent of the tumors showed positive staining for HLA-DR, and these tumors had a higher mean and median survival at 5 years compared with negative tumors. However, on multivariate analysis the difference was not statistically significant. The authors conclude that, although HLA-DR staining is associated with tumors of better prognosis, it cannot be used as an independent prognostic factor. Of the other tumor variables, only lymph-node status was of prognostic significance.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400966     DOI: 10.1002/1097-0142(19900915)66:6<1154::aid-cncr2820660613>3.0.co;2-3

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Molecular markers (PECAM-1, ICAM-3, HLA-DR) determine prognosis in primary non-Hodgkin's gastric lymphoma patients.

Authors:  Alexander Darom; Ilias P Gomatos; Emmanuel Leandros; Emmu Chatzigianni; Dimitris Panousopoulos; Manousos M Konstadoulakis; George Androulakis
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

2.  Mitomycin C directly augments the expression of HLA-DR antigen in a gastric carcinoma cell line.

Authors:  H Inoue; M Adachi; S Arinaga; H Ueo; T Akiyoshi
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

3.  Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.

Authors:  T Rodríguez; R Méndez; A Del Campo; N Aptsiauri; J Martín; G Orozco; G Pawelec; D Schadendorf; F Ruiz-Cabello; F Garrido
Journal:  Immunogenetics       Date:  2006-12-20       Impact factor: 2.846

4.  HLA antigens are candidate markers for prediction of lymph node metastasis in gastric cancer.

Authors:  K Ogoshi; T Tajima; T Mitomi; K Tsuji
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

5.  Activation by interferon-gamma of expression of ICAM-1 and MHC class II antigens in tumour cells from colorectal carcinomas.

Authors:  I Donnellan; J Cantrill; I Fraser; A Morris
Journal:  Clin Mol Pathol       Date:  1995-02

6.  Induction of intercellular adhesion molecule 1 and class II histocompatibility antigens in colorectal tumour cells expressing activated ras oncogene.

Authors:  V Stoneman; A Morris
Journal:  Clin Mol Pathol       Date:  1995-12

7.  Interactions between interferon gamma and retinoic acid with transforming growth factor beta in the induction of immune recognition molecules.

Authors:  R Darley; A Morris; J Passas; W Bateman
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

8.  Gastric cancer and Helicobacter pylori infection.

Authors:  K S Clarkson; K P West
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

9.  Sequential changes in MHC antigen expression induced by the v-Ki-ras oncogene.

Authors:  R L Darley; A G Morris
Journal:  Cancer Immunol Immunother       Date:  1993-11       Impact factor: 6.968

10.  Immunohistochemical expression of C-myc oncogene, heat shock protein 70 and HLA-DR molecules in malignant cutaneous melanoma.

Authors:  A C Lazaris; G E Theodoropoulos; K Aroni; A Saetta; P S Davaris
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.